 |
Patient Information Sheet On Advair Sere... |
<
Back to Previous Page
Article Summary: Such as Serevent Diskus, may increase the chance of asthma death in some people
Patient Information Sheet On Advair Serevent
FDA ALERT [11/2005] In some patients with asthma, medicines called “long-acting beta-agonists” (LABA) may increase the chance of death from asthma problems.
FDA has asked companies that make products containing long-acting beta-agonists, including Serevent, to give special warnings to healthcare professionals and patients about these possible risks.
Because LABAs, such as SEREVENT DISKUS, may increase the chance of asthma death in some people:
It should not be the first medicine prescribed for your asthma.
It should not be the only medicine prescribed for your asthma.
It should always be used with another asthma-controller medicine, and only after another asthma-controller, such as a low-to-medium dose inhaled corticosteroid, has not controlled your asthma.
If you or anyone you know has either taken or been prescribed Serevent for asthma or other related medical troubles, our expert lawyers are here to help you.
Contact our serevent lawyers now and obtain a case evaluation for free.
.
|
|
 |
Latest Serevent News |
|
| |
Atlanta Worst U.S. City for People with Asthma
healthfinder.gov, Jan 26, 2007
Atlanta took the top spot due to its higher-than-average crude death rate (CDR) for asthma, high year-round pollen levels...
Read more >
Improper Home Nebulizer Use Boosts Asthma Risk
healthfinder.gov, Dec 11, 2006
A new study shows that, if used improperly, they can also lead to serious asthma complications, even death....
Read more >
Medication Guide For Serevent
fda.gov, Nov 27, 2006
In patients with asthma, LABA medicines such as SEREVENT DISKUS may increase the chance of death from asthma problems....
Read more >
Improper Home Nebulizer Use Boosts Asthma Risk
healthfinder.gov, Nov 13, 2006
A new study shows that, if used improperly, they can also lead to serious asthma complications, even death....
Read more >
FDA Orders Stronger Warnings On Three Asthma Medicines
healthfinder.gov, Oct 30, 2006
The medicines belong to a class called long-acting beta 2-adrenergic agonists (LABA), which are long-acting bronchodilator medicines that help relax the muscles around th...
Read more >
FDA Recommends Continued Availability Of Serevent
gsk.com, Oct 19, 2006
Patients should be reassured that Serevent and Advair® will continue to be available for the treatment of asthma...
Read more >
FDA Orders Stronger Warnings On Three Asthma Medicines
healthfinder.gov, Oct 05, 2006
Even though LABAs decrease the frequency of asthma attacks, they can make asthma attacks more severe when they do occur...
Read more >
Asthma Drugs Get 'Black Box' Warnings
healthfinder.gov, Sep 21, 2006
A black box warning is the most serious type of warning on prescription drugs...
Read more >
Asthma Inhaler Type Could Boost Death Risk
healthfinder.gov, Sep 07, 2006
Last year, the U.S. Food and Drug Administration issued a warning that the drugs could worsen symptoms and even lead to death....
Read more >
GSK Announces New Product Labels For Serevent And Advair
Press Release, Aug 24, 2006
GSK is pleased to have reached an agreement with FDA on product labeling that is in the best interest of patients....
Read more >
Common Asthma Medication Poses Risk to Black Patients
Press Release, Aug 10, 2006
the drug may pose a slightly higher risk for respiratory and asthma-related deaths among black patients....
Read more >
Serevent and Advair Inhaler Could Boost Death Risk
Press Release, Jul 27, 2006
Risks of hospitalization and life-threatening complications also went up. ...
Read more >
Serevent Controversy Over The Drug Dangers
nlm.nih.gov, Jun 22, 2006
Compared to placebo, the "long-acting beta-agonist bronchodilator" inhalers which include Serevent and Advair more than tripled users' risk of asthma-linked death...
Read more >
Advair Serevent Medication Guide
fda.gov, May 24, 2006
This Medication Guide does not take the place of talking to your healthcare provider about your medical condition or treatment...
Read more >
Side Effects of Serevent
nlm.nih.gov, Apr 28, 2006
Dizziness, severe; feeling of choking, irritation, or swelling in throat; flushing or redness of skin...
Read more >
Serevent Gets Black Box Warning
4women.gov, Mar 17, 2006
The revised warning on Advair says the drug should only be used when other asthma drugs...
Read more >
FDA Warning On Serevent Death
fda.gov, Mar 01, 2006
But significant increase in asthma-related deaths in patients receiving salmeterol ...
Read more >
FDA Advisory On Long Acting Bronchodilators
accessdata.fda.gov, Feb 15, 2006
The manufacturers of these products have been asked to update their existing product labels with new warnings and provide a Patient Medication Guide ...
Read more >
Patient Information Sheet On Advair Serevent
fda.gov, Jan 31, 2006
Such as Serevent Diskus, may increase the chance of asthma death in some people...
Read more >
Serevent Side Effects
healthfinder.gov, Jan 16, 2006
Public Citizen has accused GlaxoSmithKline of giving misleading study results to the U.S. Food and Drug Administration on its popular asthma drug salmeterol...
Read more >
The Prescription Serevent Risks
fda.gov, Dec 05, 2005
Serevent may worsen your breathing problems...
Read more >
FDA Public Health Advisory Serevent Diskus
fda.gov, Nov 22, 2005
Serevent Diskus to update their existing product labels with new warnings and a Medication Guide for patients ...
Read more >
Serevent Use May Lead To Severe Adverse Asthma Outcomes
fda.gov, Nov 14, 2005
Salmeterol was associated with a small and statistically non-significant excess of asthma related death compared to chronic use of albuterol ...
Read more >
Watchdog Group Claims GlaxoSmithKline Misled FDA
4woman.gov, Oct 17, 2005
This drug has been given out presumably to decrease deaths from asthma where in fact it increases death. ...
Read more >
Recall of Asthma Medicines Sold in Canada
fda.gov, Sep 01, 2005
As a precaution, the Food and Drug Administration (FDA) is alerting U.S. residents to the recent recall ...
Read more >
Controlled On Theophylline Inhaled Serevent
ehp.niehs.nih.gov, Aug 11, 2005
She Was Controlled On Theophylline Inhaled Serevent...
Read more >
Patients Who Are Currently Taking Serevent
fda.gov, Aug 05, 2005
Patients Who Are Currently Taking Serevent Should Not Discontinue Their Treatment Without First Consulting A Physician...
Read more >
Experts Call For Warning Label On Asthma Drug
fda.com, Jul 25, 2005
Serevent are in the same category of drugs and share similar side-effects...
Read more >
The Combined Number Of Respiratory-Related Deaths And Respiratory-Related Life-Threatening Experiences
FDA, May 05, 2005
The Combined Number Of Respiratory-Related Deaths And Respiratory-Related Life-Threatening Experiences...
Read more >
Glaxosmithkline's (GSK) Asthma Medication, Serevent, Increasing The Risks Of Dying Of Asthma
rimadyl death, Apr 25, 2005
Pharma Stocks Under Pressure Five Popular Drugs Dangerous...
Read more >
Drug Maker Stands Firmly Behind Serevent Despite Warnings
drug-warnings, Mar 30, 2005
Drug Maker Stands Firmly Behind Serevent Despite Warnings and Posible Dangers Additional Serevent Information, Dangers and Warnings...
Read more >
Drug Maker Stands Firmly Behind Serevent Despite Warnings
uture-rx, Mar 23, 2005
Drug Maker Stands Firmly Behind Serevent Despite Warnings and Possible Dangers...
Read more >
Important Revisions To Prescribing Information For Serevent
fda, Mar 16, 2005
Important Revisions To Prescribing Information For Serevent...
Read more >
The FDA, To Assess The Safety Of Serevent Warning Following Concerns Regarding The Safety
fda.gov, Mar 15, 2005
The FDA, To Assess The Safety Of Serevent Warning Following Concerns Regarding The Safety Of Regular Use Of Short-Acting And Long-Acting ß2-Agonists...
Read more >
Ozone Friendly Formulation, Flovent HFA Fluticasone Propionate HFA Inhalation Aerosol, Now Available
biz.yahoo, Mar 08, 2005
Over the past two decades, GlaxoSmithKline has invested hundreds of millions of dollars in its efforts to develop effective alternatives to CFC formulations...
Read more >
Important New Safety Information About Serevent
fda gov, Feb 28, 2005
GlaxoSmithKline is writing to you, as a prescriber of Serevent (salmeterol xinafoate), to communicate important safety information, and reinforce and reiterate advice on ...
Read more >
More Serevent-Related News>
|
|
|
|
Regional Resources |
|
| |
Search for Serevent-related resources in your State:
|
|
| |
|
|
|
| |
|
|
|
|
|
| |
Did You Know? |
|
| |
Consumer advocacy websites like WorstPills.org, Best Pills News listed the asthma drug salmeterol (SEREVENT) as a DO NOT USE drug after the Food and Drug Administration (FDA) announced on January 23, 2003 that a large safety study involving the drug had been halted prematurely because an interim analysis of outcomes suggested that the drug may be associated with an increased risk of life-threatening asthma episodes or asthma-related deaths.
|
|
|
| |
|
